ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study

Jennifer A. Doherty, Mary Anne Rossing, Kara L. Cushing-Haugen, Chu Chen, David J. Van Den Berg, Anna H. Wu, Malcolm C. Pike, Roberta B. Ness, Kirsten Moysich, Georgia Chenevix-Trench, Jonathan Beesley, Penelope M. Webb, Jenny Chang-Claude, Shan Wang-Gohrke, Marc T. Goodman, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Estrid Hogdall, Susanne Kruger KjaerClaus Hogdall, Ellen L Goode, Julie M Cunningham, Brooke L. Fridley, Robert A. Vierkant, Andrew Berchuck, Patricia G. Moorman, Joellen M. Schildkraut, Rachel T. Palmieri, Daniel W. Cramer, Kathryn L. Terry, Hannah P. Yang, Montserrat Garcia-Closas, Stephen Chanock, Jolanta Lissowska, Honglin Song, Paul D P Pharoah, Mitul Shah, Barbara Perkins, Valerie McGuire, Alice S. Whittemore, Richard A. Di Cioccio, Aleksandra Gentry-Maharaj, Usha Menon, Simon A. Gayther, Susan J. Ramus, Argyrios Ziogas, Wendy Brewster, Hoda Anton-Culver, Celeste Leigh Pearce

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95% confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95% CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95% CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95% CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer.

Original languageEnglish (US)
Pages (from-to)245-250
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Ovarian Neoplasms
Alleles
Odds Ratio
Confidence Intervals
Single Nucleotide Polymorphism
Spectrin
Cytokinesis
Estrogen Receptor alpha
Nuclear Envelope
Linkage Disequilibrium
Golgi Apparatus
Genes
Case-Control Studies
Protein Isoforms
Down-Regulation
Ovarian epithelial cancer
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Doherty, J. A., Rossing, M. A., Cushing-Haugen, K. L., Chen, C., Van Den Berg, D. J., Wu, A. H., ... Pearce, C. L. (2010). ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study. Cancer Epidemiology Biomarkers and Prevention, 19(1), 245-250. https://doi.org/10.1158/1055-9965.EPI-09-0729

ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk : An Ovarian Cancer Association Consortium Study. / Doherty, Jennifer A.; Rossing, Mary Anne; Cushing-Haugen, Kara L.; Chen, Chu; Van Den Berg, David J.; Wu, Anna H.; Pike, Malcolm C.; Ness, Roberta B.; Moysich, Kirsten; Chenevix-Trench, Georgia; Beesley, Jonathan; Webb, Penelope M.; Chang-Claude, Jenny; Wang-Gohrke, Shan; Goodman, Marc T.; Lurie, Galina; Thompson, Pamela J.; Carney, Michael E.; Hogdall, Estrid; Kjaer, Susanne Kruger; Hogdall, Claus; Goode, Ellen L; Cunningham, Julie M; Fridley, Brooke L.; Vierkant, Robert A.; Berchuck, Andrew; Moorman, Patricia G.; Schildkraut, Joellen M.; Palmieri, Rachel T.; Cramer, Daniel W.; Terry, Kathryn L.; Yang, Hannah P.; Garcia-Closas, Montserrat; Chanock, Stephen; Lissowska, Jolanta; Song, Honglin; Pharoah, Paul D P; Shah, Mitul; Perkins, Barbara; McGuire, Valerie; Whittemore, Alice S.; Di Cioccio, Richard A.; Gentry-Maharaj, Aleksandra; Menon, Usha; Gayther, Simon A.; Ramus, Susan J.; Ziogas, Argyrios; Brewster, Wendy; Anton-Culver, Hoda; Pearce, Celeste Leigh.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 1, 01.2010, p. 245-250.

Research output: Contribution to journalArticle

Doherty, JA, Rossing, MA, Cushing-Haugen, KL, Chen, C, Van Den Berg, DJ, Wu, AH, Pike, MC, Ness, RB, Moysich, K, Chenevix-Trench, G, Beesley, J, Webb, PM, Chang-Claude, J, Wang-Gohrke, S, Goodman, MT, Lurie, G, Thompson, PJ, Carney, ME, Hogdall, E, Kjaer, SK, Hogdall, C, Goode, EL, Cunningham, JM, Fridley, BL, Vierkant, RA, Berchuck, A, Moorman, PG, Schildkraut, JM, Palmieri, RT, Cramer, DW, Terry, KL, Yang, HP, Garcia-Closas, M, Chanock, S, Lissowska, J, Song, H, Pharoah, PDP, Shah, M, Perkins, B, McGuire, V, Whittemore, AS, Di Cioccio, RA, Gentry-Maharaj, A, Menon, U, Gayther, SA, Ramus, SJ, Ziogas, A, Brewster, W, Anton-Culver, H & Pearce, CL 2010, 'ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study', Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 1, pp. 245-250. https://doi.org/10.1158/1055-9965.EPI-09-0729
Doherty, Jennifer A. ; Rossing, Mary Anne ; Cushing-Haugen, Kara L. ; Chen, Chu ; Van Den Berg, David J. ; Wu, Anna H. ; Pike, Malcolm C. ; Ness, Roberta B. ; Moysich, Kirsten ; Chenevix-Trench, Georgia ; Beesley, Jonathan ; Webb, Penelope M. ; Chang-Claude, Jenny ; Wang-Gohrke, Shan ; Goodman, Marc T. ; Lurie, Galina ; Thompson, Pamela J. ; Carney, Michael E. ; Hogdall, Estrid ; Kjaer, Susanne Kruger ; Hogdall, Claus ; Goode, Ellen L ; Cunningham, Julie M ; Fridley, Brooke L. ; Vierkant, Robert A. ; Berchuck, Andrew ; Moorman, Patricia G. ; Schildkraut, Joellen M. ; Palmieri, Rachel T. ; Cramer, Daniel W. ; Terry, Kathryn L. ; Yang, Hannah P. ; Garcia-Closas, Montserrat ; Chanock, Stephen ; Lissowska, Jolanta ; Song, Honglin ; Pharoah, Paul D P ; Shah, Mitul ; Perkins, Barbara ; McGuire, Valerie ; Whittemore, Alice S. ; Di Cioccio, Richard A. ; Gentry-Maharaj, Aleksandra ; Menon, Usha ; Gayther, Simon A. ; Ramus, Susan J. ; Ziogas, Argyrios ; Brewster, Wendy ; Anton-Culver, Hoda ; Pearce, Celeste Leigh. / ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk : An Ovarian Cancer Association Consortium Study. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 1. pp. 245-250.
@article{8a3a9b6985a74e178b0cd8adc409af0d,
title = "ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study",
abstract = "We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95{\%} confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95{\%} CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95{\%} CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95{\%} CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer.",
author = "Doherty, {Jennifer A.} and Rossing, {Mary Anne} and Cushing-Haugen, {Kara L.} and Chu Chen and {Van Den Berg}, {David J.} and Wu, {Anna H.} and Pike, {Malcolm C.} and Ness, {Roberta B.} and Kirsten Moysich and Georgia Chenevix-Trench and Jonathan Beesley and Webb, {Penelope M.} and Jenny Chang-Claude and Shan Wang-Gohrke and Goodman, {Marc T.} and Galina Lurie and Thompson, {Pamela J.} and Carney, {Michael E.} and Estrid Hogdall and Kjaer, {Susanne Kruger} and Claus Hogdall and Goode, {Ellen L} and Cunningham, {Julie M} and Fridley, {Brooke L.} and Vierkant, {Robert A.} and Andrew Berchuck and Moorman, {Patricia G.} and Schildkraut, {Joellen M.} and Palmieri, {Rachel T.} and Cramer, {Daniel W.} and Terry, {Kathryn L.} and Yang, {Hannah P.} and Montserrat Garcia-Closas and Stephen Chanock and Jolanta Lissowska and Honglin Song and Pharoah, {Paul D P} and Mitul Shah and Barbara Perkins and Valerie McGuire and Whittemore, {Alice S.} and {Di Cioccio}, {Richard A.} and Aleksandra Gentry-Maharaj and Usha Menon and Gayther, {Simon A.} and Ramus, {Susan J.} and Argyrios Ziogas and Wendy Brewster and Hoda Anton-Culver and Pearce, {Celeste Leigh}",
year = "2010",
month = "1",
doi = "10.1158/1055-9965.EPI-09-0729",
language = "English (US)",
volume = "19",
pages = "245--250",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk

T2 - An Ovarian Cancer Association Consortium Study

AU - Doherty, Jennifer A.

AU - Rossing, Mary Anne

AU - Cushing-Haugen, Kara L.

AU - Chen, Chu

AU - Van Den Berg, David J.

AU - Wu, Anna H.

AU - Pike, Malcolm C.

AU - Ness, Roberta B.

AU - Moysich, Kirsten

AU - Chenevix-Trench, Georgia

AU - Beesley, Jonathan

AU - Webb, Penelope M.

AU - Chang-Claude, Jenny

AU - Wang-Gohrke, Shan

AU - Goodman, Marc T.

AU - Lurie, Galina

AU - Thompson, Pamela J.

AU - Carney, Michael E.

AU - Hogdall, Estrid

AU - Kjaer, Susanne Kruger

AU - Hogdall, Claus

AU - Goode, Ellen L

AU - Cunningham, Julie M

AU - Fridley, Brooke L.

AU - Vierkant, Robert A.

AU - Berchuck, Andrew

AU - Moorman, Patricia G.

AU - Schildkraut, Joellen M.

AU - Palmieri, Rachel T.

AU - Cramer, Daniel W.

AU - Terry, Kathryn L.

AU - Yang, Hannah P.

AU - Garcia-Closas, Montserrat

AU - Chanock, Stephen

AU - Lissowska, Jolanta

AU - Song, Honglin

AU - Pharoah, Paul D P

AU - Shah, Mitul

AU - Perkins, Barbara

AU - McGuire, Valerie

AU - Whittemore, Alice S.

AU - Di Cioccio, Richard A.

AU - Gentry-Maharaj, Aleksandra

AU - Menon, Usha

AU - Gayther, Simon A.

AU - Ramus, Susan J.

AU - Ziogas, Argyrios

AU - Brewster, Wendy

AU - Anton-Culver, Hoda

AU - Pearce, Celeste Leigh

PY - 2010/1

Y1 - 2010/1

N2 - We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95% confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95% CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95% CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95% CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer.

AB - We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95% confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95% CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95% CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95% CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=74549167142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549167142&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0729

DO - 10.1158/1055-9965.EPI-09-0729

M3 - Article

C2 - 20056644

AN - SCOPUS:74549167142

VL - 19

SP - 245

EP - 250

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -